GDF-15 and suPAR biomarkers provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
Do GDF-15 and suPAR provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention?
GDF-15 and suPAR offer incremental prognostic value for short-term risk stratification following transcatheter tricuspid valve intervention.
Absolute Event Rate: 0% vs 0%
GDF-15 and suPAR provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.
Edlinger et al. (Mon,) reported a other. GDF-15 and suPAR biomarkers provide incremental prognostic value for short-term risk stratification after transcatheter tricuspid valve intervention.